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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to 
non-digestible carbohydrates and a reduction of post-prandial glycaemic 
responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006
1 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Beneo-Orafti SA, Sensus BV and Cosucra-Groupe Warcoing SA, submitted for 
authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent 
Authority of Belgium, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver 
an opinion on the scientific substantiation of a health claim related to fructo-oligosaccharides (FOS) from inulin 
and a reduction of post-prandial glycaemic responses. Non-digestible carbohydrates including FOS are resistant 
to hydrolysis and absorption in the small intestine and do not contribute to post-prandial glycaemia. This opinion 
applies to non-digestible carbohydrates (e.g. non-starch polysaccharides, resistant oligosaccharides and resistant 
starch) which should replace sugars in foods or beverages in order to obtain the claimed effect. The Panel 
considers that the food constituent, non-digestible carbohydrates, which is the subject of the health claim, and the 
food constituent (i.e. sugars) that non-digestible carbohydrates should replace in foods or beverages, are both 
sufficiently characterised in relation to the claimed effect. The Panel considers that a reduction of post-prandial 
glycaemic responses might be a beneficial physiological effect. In weighing the evidence, the Panel took into 
account that consumption of non-digestible carbohydrates results in reduced post-prandial blood glucose (and 
insulinaemic) responses compared with the consumption of sugars on a weight-by-weight basis owing to the non-
digestibility  in  the  small  intestine  and  to  a  decrease  in  the amount of available carbohydrates, and that the 
consumption of foods/drinks in which non-digestible carbohydrates replaced sugars induced lower post-prandial 
glycaemic and insulinaemic responses than sugar-containing foods/drinks. The Panel concludes that a cause and 
effect relationship has been established between the consumption of foods/beverages containing non-digestible 
carbohydrates  instead  of  sugar  and  a reduction of post-prandial glycaemic responses as compared to sugar-
containing foods/beverages. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following  an  application  from  Beneo-Orafti  SA,  Sensus  BV  and  Cosucra-Groupe  Warcoing  SA, 
submitted  for  authorisation  of  a  health  claim  pursuant  to  Article 13(5)  of  Regulation  (EC) 
No 1924/2006  via  the  Competent  Authority  of  Belgium,  the  EFSA  Panel  on  Dietetic  Products, 
Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a 
health claim related to fructo-oligosaccharides (FOS) from inulin and a reduction of post-prandial 
glycaemic responses. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. The application included a request for the protection of proprietary data. 
The  food  that  is  the  subject  of  the  health  claim  is  fructo-oligosaccharides  (FOS,  oligofructose) 
obtained  from  chicory  (Cichorium  intybus  L.)  inulin,  which  should  replace  sugars  (i.e. 
monosaccharides and disaccharides) in foods or beverages in order to obtain the claimed effect (i.e. 
reduction of post-prandial glycaemic responses). The Panel notes that the characteristic which is most 
relevant to the claimed effect is not unique to FOS but common to other non-digestible carbohydrates 
(e.g. non-starch polysaccharides, resistant oligosaccharides, resistant starch) because, similar to FOS, 
non-digestible carbohydrates are resistant to hydrolysis and absorption in the small intestine and do 
not contribute to post-prandial glycaemia. This opinion applies to non-digestible carbohydrates (e.g. 
non-starch  polysaccharides,  resistant  oligosaccharides  and  resistant  starch)  which  should  replace 
sugars in foods or beverages in order to obtain the claimed effect. The Panel considers that the food 
constituent,  non-digestible  carbohydrates,  which  is  the  subject  of  the  health  claim,  and  the  food 
constituent (i.e. sugars) that non-digestible carbohydrates should replace in foods or beverages, are 
both sufficiently characterised in relation to the claimed effect. 
The claimed effect proposed by the applicant relates to the reduction of post-prandial blood glucose 
responses.  The  target  population  proposed  by  the  applicant  is  the  general  population.  The  Panel 
considers that a reduction of post-prandial glycaemic responses (as long as post-prandial insulinaemic 
responses are not disproportionally increased) might be a beneficial physiological effect. 
The applicant identified a total of three human intervention studies and three human mechanistic 
studies as being pertinent to the health claim. 
One cross-over trial assessed the effects of test ice creams where the sucrose content was replaced by 
various sugar replacers on post-prandial blood glucose responses relative to a control ice-cream which 
contained sucrose. Consumption of the test ice creams elicited significantly lower glucose incremental 
area under the curve (iAUC) (with the exception of maltitol and maltitol/resistant dextrin containing 
ice-creams) than the sucrose-containing control ice cream. 
A randomised cross-over trial assessed post-prandial glycaemic responses following consumption of a 
long  chain  inulin,  “native”  inulin,  and  two  FOS-containing  products.  Relative  to  the  glucose 
containing  drink,  glycaemic  responses  were  significantly  lower  after  consumption  of  long-chain 
inulin, “native” inulin and the two FOS-containing products. 
One double-blind, randomised, cross-over study was carried out with a yoghurt with 20 % of the 
sucrose  replaced  by  FOS  derived  from chicory inulin. Compared  with the reference yoghurt, the 
glucose  iAUC  was  significantly  decreased  following  consumption  of  the  sugar-reduced  yoghurt. 
There was also a significant reduction in the peak blood glucose values and the insulin iAUC values, 
whereas no differences were reported for the peak insulin responses. 
The three mechanistic studies addressed the non-digestibility of FOS in the human small intestine, 
which, according to the applicant, constitutes the underlying mechanism for the claimed effect. Non-digestible carbohydrates and reduction of post-prandial glycaemic responses   
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It  is  well  established  that  sugars  increase  post-prandial  glycaemia.  Non-digestible  carbohydrates 
including FOS are resistant to hydrolysis and absorption in the small intestine and do not contribute to 
post-prandial  glycaemia.  The  Panel  considers  that  replacing  sugars  by  any  non-digestible 
carbohydrate (e.g. non-starch polysaccharides, resistant oligosaccharides and resistant starch) would 
contribute to the claimed effect, i.e. a reduction of post-prandial glycaemic responses. 
In  weighing  the  evidence,  the  Panel  took  into  account  that  consumption  of  non-digestible 
carbohydrates results in reduced post-prandial blood glucose (and insulinaemic) responses compared 
with the consumption of sugars on a weight-by-weight basis owing to the non-digestibility in the 
small intestine and to a decrease in the amount of available carbohydrates, and that the consumption 
of foods/drinks in which non-digestible carbohydrates replaced sugars induced lower post-prandial 
glycaemic and insulinaemic responses than sugar-containing foods/drinks. 
The  Panel  concludes  that  a  cause  and  effect  relationship  has  been  established  between  the 
consumption  of  foods/beverages  containing  non-digestible  carbohydrates  instead  of  sugars  and 
reduction of post-prandial glycaemic responses as compared to sugar-containing foods/beverages. 
The following wording reflects the scientific evidence: “Consumption of foods/drinks containing non-
digestible carbohydrates instead of sugars induces a lower blood glucose rise after meals compared to 
sugar-containing foods/drinks”. 
The Panel considers that in order to bear the claim sugars (i.e. monosaccharides and disaccharides) 
should be replaced in foods or drinks by non-digestible carbohydrates so that foods or drinks contain 
reduced amounts of sugars as per Annex of Regulation (EC) No 1924/2006 and in accordance with 
the Guidance on the implementation of Regulation (EC) No 1924/2006 of the Standing Committee on 
the  Food  Chain  and  Animal  Health  for  comparative  nutrition  claims  made  on  foods.  The  target 
population is individuals who wish to reduce their post-prandial blood glucose responses. Non-digestible carbohydrates and reduction of post-prandial glycaemic responses   
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BACKGROUND 
Regulation (EC) No 1924/2006
4 harmonises the provisions that relate to nutrition and health claims , 
and establishes rules governing the Community authorisation of health claims made on  foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of  
this Regulation, are authorised in accordance with this Regulation , and are included in the lists of 
authorised claims provided for in Articles  13 and 14 thereof. In particular,  Article 13(5) of this  
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to chi ldren’s  development  and  health)  which  are  based  on  newly  developed 
scientific  evidence,  or  which  include  a  request  for  the  protection  of  proprietary  data,  to  the 
Community list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted  claims  referred  to  in  Article 13(3)  shall  be  submitted  by  the  applicant  to  the  national 
competent authority of a Member State, which will make the application and any supplementary 
information supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA 
  The application was received on 18/06/2013. 
  The  scope  of  the  application  was  proposed  to  fall  under  a  health  claim  based  on  newly 
developed  scientific  evidence.  The  application  included  a  request  for  the  protection  of 
proprietary data. 
  The scientific evaluation procedure started on 08/08/2013. 
  On 26/09/2013, the Working Group on Claims of the NDA Panel agreed on a list of questions 
for the applicant to provide additional information to accompany the application and the clock 
was  stopped  on  09/10/2013,  in  compliance  with  Article 18(3)  of  Regulation  (EC)  No 
1924/2006. 
  On 18/10/2013, EFSA received the requested information and the clock was restarted,  in 
compliance with Article 18(3) of Regulation (EC) No 1924/2006. 
  During  its  meeting  on  11/12/2013,  the  NDA  Panel,  having  evaluated  the  data  submitted, 
adopted an opinion on the scientific substantiation of a health claim related to non-digestible 
carbohydrates and reduction of post-prandial glycaemic responses. 
TERMS OF REFERENCE 
EFSA  is  requested  to  evaluate  the  scientific  data  submitted  by  the  applicant  in  accordance  with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: non-digestible carbohydrates and a 
reduction of post-prandial glycaemic responses. 
EFSA DISCLAIMER 
The  present  opinion  does  not  constitute,  and  cannot  be  construed  as,  an  authorisation  for  the 
marketing of non-digestible carbohydrates, a positive assessment of their safety, nor a decision on 
whether non-digestible carbohydrates are, or are not, classified as a foodstuff. It should be noted that 
such an assessment is not foreseen in the framework of Regulation (EC) No 1924/2006. 
                                                       
4  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. Non-digestible carbohydrates and reduction of post-prandial glycaemic responses   
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It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. Non-digestible carbohydrates and reduction of post-prandial glycaemic responses   
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INFORMATION PROVIDED BY THE APPLICANT 
Applicants’ names and addresses: Beneo-Orafti SA, Rue L. Maréchal 1, B-4360 Oreye, Belgium. 
Sensus BV, Borchwerf 3, 4704 RG Roosendaal, The Netherlands. Cosucra-Groupe Warcoing SA, 1, 
Rue de la Sucrerie, B-7740 Warcoing, Belgium. 
The application includes a request for the protection of proprietary data for one unpublished study 
(Thondre and Lightowler, 2012), in accordance with Article 21 of Regulation (EC) No 1924/2006. 
Food/constituent as stated by the applicant 
According to the applicant, the food that is the subject of the health claim is fructo-oligosaccharides 
(FOS, oligofructose) obtained from chicory (Cichorium intybus L.) inulin. 
Health relationship as claimed by the applicant 
According to the applicant, the consumption of foods/drinks containing FOS from chicory instead of 
sugars leads to a reduced blood glucose rise. The applicant claimed that this effect is owing to the 
non-digestibility of FOS in the small intestine of humans. 
Wording of the health claim as proposed by the applicant 
The applicant has proposed the following wording for the health claim: “Consumption of foods/drinks 
containing oligofructose from chicory instead of sugars induces a lower blood glucose rise”. 
The  following  alternative  wordings  were  proposed:  “Foods/drinks  containing  oligofructose  from 
chicory instead of sugars: 
- induce a lower blood glucose rise after their consumption”. 
- attenuates post-prandial blood glucose response/glycaemia”. 
- contributes to a reduction of post-prandial blood glucose responses”. 
- supports a lower post-prandial blood glucose response”. 
- helps to reduce/lower post-prandial blood glucose response”. 
- helps to maintain a lower post-prandial blood glucose response”. 
Specific conditions of use as proposed by the applicant 
According to the applicant, the claimed effect can be obtained with a single intake of a food in which 
sugars have been partially (at least 20 %) or completely replaced by FOS from chicory on a weight-
by-weight basis. 
The target population proposed by the applicant is the general population. 
ASSESSMENT 
1.  Characterisation of the food/constituent 
The  food  that  is  the  subject  of  the  health  claim  is  fructo-oligosaccharides  (FOS,  oligofructose) 
obtained  from  chicory  (Cichorium  intybus  L.)  inulin,  which  should  replace  sugars  in  foods  or 
beverages in order to obtain the claimed effect (i.e. reduction of post-prandial glycaemic responses). 
The FOS which was proposed by the applicant as the food which is the subject of the health claim is 
obtained  from  inulin  extracted  from  chicory  (Cichorium  intybus  L.)  roots.  An  overview  of  the 
manufacturing process, stability data and batch-to-batch variability were provided. Non-digestible carbohydrates and reduction of post-prandial glycaemic responses   
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The applicant proposes to replace sugars with FOS from chicory inulin in a variety of food products 
(e.g.  dairy  products,  edible  ices,  confectionery,  cereal  products,  bakery  wares,  soups  and  sauces, 
beverages, savouries, snacks, desserts, food supplements and other processed foods). 
From the information provided, the Panel notes that the main characteristic of FOS from chicory 
inulin which contributes to the claimed effect is the non-digestibility of FOS in the small intestine, 
and  that  replacing  digestible  (glycaemic)  carbohydrates  (e.g.  sugars)  by  any  non-digestible 
carbohydrate would contribute to the claimed effect. The applicant was requested to indicate  the 
characteristics or properties of FOS from chicory inulin which make it unique as compared to other 
non-digestible carbohydrates in relation to the claimed effect. In reply, the applicant stated that the 
claim should be restricted to FOS from chicory because “this was the scientific basis of the dossier”. 
The applicant also commented on regulatory issues but did not provide scientific arguments/evidence 
for an effect of FOS from chicory on the reduction of post-prandial blood glucose concentrations 
when replacing sugars in foods beyond what could be expected  by the replacement of digestible 
(glycaemic) carbohydrates by non-digestible carbohydrates. 
The Panel notes that the characteristic which is most relevant to the claimed effect (i.e. reduction of 
post-prandial glycaemic responses by replacing sugars in foods and beverages) is not unique to FOS 
but  common  to  other  non-digestible  carbohydrates  (e.g.  non-starch  polysaccharides,  resistant 
oligosaccharides, resistant starch) because, similar to FOS, non-digestible carbohydrates are resistant 
to hydrolysis and absorption in the small intestine and therefore do not contribute to post-prandial 
glycaemia. 
This  opinion  applies  to  non-digestible  carbohydrates  (e.g.  non-starch  polysaccharides,  resistant 
oligosaccharides  and resistant starch; EFSA NDA Panel, 2010) which should replace  sugars (i.e. 
monosaccharides and disaccharides) in foods or beverages in order to obtain the claimed effect. The 
Panel notes that non-digestible carbohydrates have a neutral taste and cannot substitute for the sweet 
taste of sugars. 
The Panel considers that the food constituent, non-digestible carbohydrates, which is the subject of 
the  health  claim,  and  the  food  constituent  (i.e.  sugars)  that  non-digestible  carbohydrates  should 
replace in foods or beverages, are both sufficiently characterised in relation to the claimed effect. 
2.  Relevance of the claimed effect to human health 
The claimed effect proposed by the applicant relates to the reduction of post-prandial blood glucose 
responses. The target population proposed by the applicant is the general population. 
The elevation of blood glucose concentrations after consumption of a food and/or meal, i.e. post-
prandial glycaemia, is a normal physiological response which varies in magnitude and duration, and 
which may be influenced by the chemical and physical nature of the food or meal consumed, as well 
as by individual factors (Venn and Green, 2007). Decreasing post-prandial glycaemic responses may, 
for example, be beneficial to individuals with impaired glucose tolerance, as long as post-prandial 
insulinaemic responses are not disproportionally increased. Impaired glucose tolerance is common in 
the general population of adults. 
The Panel considers that a reduction of post-prandial glycaemic responses (as long as post-prandial 
insulinaemic responses are not disproportionally increased) might be a beneficial physiological effect. 
3.  Scientific substantiation of the claimed effect 
The applicant performed a literature search in Medline, EMBASE and CAplus using the search terms 
“fructan” or “fructane” or “fructans” or “FOS” or “fructooligosaccharide*” or “fructo-oligosacch*” or 
“inulin”  or  “inulin-type  fructan”  or  “oligofructose”  or  “oligo-fructose”  or  “fructose  cont* Non-digestible carbohydrates and reduction of post-prandial glycaemic responses   
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oligosaccharide*” AND “glycem*” or “glycaem*” or “hyperglycem*” or “hyperglycaem*” or “hyper-
glycem*”  or  “hyper-glycaem*”  OR  “blood  glucose*”  or  “bloodglucose*”  or  “blutglukose”  or 
“blutglucose*” or “blood sugar*” or “blutzucker” or “blood dextrose*” or “blooddextrose*”. The only 
limits set in the search strategy were the exclusion of patents and duplicates. The search was carried 
out on 7 November 2012, with an update on 25 April 2013. In addition to the literature search in the 
databases mentioned above, alternative search strategies (e.g. internet, Pubmed) were performed to 
identify further possibly pertinent studies. Studies were included if they contained primary data of 
post-prandial blood glucose response tests (oral intake) of FOS used as a sugar replacer in comparison 
with  reference  products  containing  traditional  glycaemic  sugars  and determined in humans under 
equal conditions; if the duration of the blood glucose response test was at least 120 minutes; and if the 
subjects were healthy without regular medication with potential effects on blood glucose response, 
not diabetic and not pregnant or lactating. Studies were excluded if they used FOS not to replace 
sugars but in addition to normal sugar content (e.g. as a fat replacer); if they used other fructans than 
FOS from chicory (e.g. inulin from chicory or fructans derived from Jerusalem artichoke or short-
chain fructo-oligosaccharides derived from sucrose); or if they used FOS from chicory in combination 
with probiotics or other fructans or fibres. 
The applicant identified a total of three human intervention studies (Hull et al., 2005, unpublished; 
Meyer,  2007;  Thondre  and  Lightowler,  2012,  unpublished)  and  three  human  mechanistic  studies 
(Ellegård et al., 1997; Rumessen and Gudmand-Høyer, 1998; Teuri et al., 1999) as being pertinent to 
the health claim. 
One cross-over trial (Hull et al., 2005, unpublished) in 12 subjects assessed the effects of test ice 
creams, where the sucrose content was replaced by various sugar replacers (mostly polyols, but also 
FOS),  on  post-prandial  blood  glucose  responses  relative  to  a  control  ice  cream  (15 %  sucrose). 
Consumption of the test ice creams elicited a significantly lower glucose incremental area under the 
curve (iAUC) (with the exception of maltitol and maltitol/resistant dextrin containing ice-creams) 
than the sucrose-containing ice cream. 
A randomised cross-over trial (Meyer, 2007) assessed post-prandial glycaemic responses following 
consumption  of  a  long-chain  inulin  (degree  of  polymerisation  (DP) 23,  mono-  and  disaccharide 
content less than 0.5 %), “native” inulin (DP 9-10, 8 % mono- and disaccharides), and two FOS-
containing  products  with  varying  percentages  of  mono-  and  disaccharides  (i.e.  15 %  and  40 %, 
respectively). Study subjects received 25 g glucose or 25 g of the above test products dissolved in 
water. Relative to the glucose-containing drink, glycaemic responses were significantly lower after 
consumption  of  long-chain  inulin  (5 ± 2 %  of  the  glucose  drink),  native  inulin  (14 ± 3 %  of  the 
glucose drink) and the two FOS-containing products (20 ± 5 % and 48 ± 6 %, respectively, of the 
glucose drink). 
One  double-blind,  randomised,  cross-over  study  (Thondre  and  Lightowler,  2012,  unpublished, 
claimed as proprietary by the applicant) in 40 subjects was carried out with a yoghurt with 20 % of 
the sucrose replaced (on a weight-by-weight basis) by FOS derived from chicory inulin. Compared 
with the reference yoghurt, the glucose iAUC was significantly reduced following consumption of the 
sugar-reduced yoghurt. There was also a significant reduction in the peak blood glucose values and 
the insulin iAUC values, whereas no differences were reported for the peak insulin responses. 
The three mechanistic studies (Ellegård et al., 1997; Rumessen and Gudmand-Høyer, 1998; Teuri et 
al., 1999) addressed the non-digestibility of FOS in the human small intestine which, according to the 
applicant, constitutes the underlying mechanism for the claimed effect. Non-digestible carbohydrates and reduction of post-prandial glycaemic responses   
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It  is  well  established  that  sugars  increase  post-prandial  glycaemia.  Non-digestible  carbohydrates 
including FOS are resistant to hydrolysis and absorption in the small intestine and do not contribute to 
post-prandial  glycaemia.  The  Panel  considers  that  replacing  sugars  by  any  non-digestible 
carbohydrate (e.g. non-starch polysaccharides, resistant oligosaccharides and resistant starch; EFSA 
NDA Panel, 2010) would contribute to the claimed effect, i.e. a reduction of post-prandial glycaemic 
responses. 
A claim related to sugar replacers and reduction of post-prandial glycaemic responses has already 
been assessed by the Panel with a favourable outcome (EFSA NDA Panel, 2011). The scientific 
substantiation of the claim was based on the reduced post-prandial blood glucose (or insulinaemic) 
responses induced by sugar replacers compared with sugars on a weight-by-weight basis owing to 
their  reduced/delayed  digestion/absorption  and/or  to  a  decrease  in  the  amount  of  available 
carbohydrates,  and  on  the  lower  post-prandial  glycaemic  and  insulinaemic  responses  induced  by 
foods/drinks containing sugar replacers compared with sugar-containing foods/drinks. 
In  weighing  the  evidence,  the  Panel  took  into  account  that  consumption  of  non-digestible 
carbohydrates results in reduced post-prandial blood glucose (and insulinaemic) responses compared 
with the consumption of sugars on a weight-by-weight basis owing to non digestibility in the small 
intestine and to a decrease in the amount of available carbohydrates, and that the consumption of 
foods/drinks  in  which  non-digestible  carbohydrates  replaced  sugars  induced  lower  post-prandial 
glycaemic and insulinaemic responses than sugar-containing foods/drinks. 
The  Panel  concludes  that  a  cause  and  effect  relationship  has  been  established  between  the 
consumption  of  foods/beverages  containing  non-digestible  carbohydrates  instead  of  sugars  and  a 
reduction of post-prandial glycaemic responses as compared to sugar-containing foods/beverages. 
The Panel could have reached this conclusion without the human study (Thondre and Lightowler, 
2012, unpublished) claimed as proprietary by the applicant. 
4.  Panel’s comments on the proposed wording 
The Panel considers that the following wording reflects the scientific evidence:  “Consumption of 
foods/drinks containing non-digestible carbohydrates instead of sugars induces a lower blood glucose 
rise after meals compared to sugar-containing foods/drinks”. 
5.  Conditions and restrictions of use 
The Panel considers that, in order to bear the claim, sugars (i.e. monosaccharides and disaccharides) 
should be replaced in foods or drinks by non-digestible carbohydrates so that foods or drinks contain 
reduced amounts of sugars as per Annex of Regulation (EC) No 1924/2006 and in accordance with 
the Guidance on the implementation of Regulation (EC) No 1924/2006 of the Standing Committee on 
the Food Chain and Animal Health for comparative nutrition claims made on foods
5. 
The target population is individuals who wish to reduce their post-prandial blood glucose responses. 
The Panel notes that  non-digestible carbohydrates have a neutral taste and cannot substitute for the 
sweet taste of sugars. 
                                                       
5  Guidance  on the implementation of Regulation (EC) No 1924/2006  on nutrition and health claims made on foods  – 
Conclusions of the Standing Committee on the Food Chain and Animal Health, 14 December 2007.  Non-digestible carbohydrates and reduction of post-prandial glycaemic responses   
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CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
  The food constituent, non-digestible carbohydrates, which is the subject of the health claim, 
and the food constituent (i.e. sugars) that non-digestible carbohydrates should replace in foods 
or beverages, are both sufficiently characterised in relation to the claimed effect. 
  The claimed effect proposed by the applicant relates to the reduction of post-prandial blood 
glucose responses. The target population proposed by the applicant is the general population. 
Reduction  of  post-prandial  glycaemic  responses  (as  long  as  post-prandial  insulinaemic 
responses are not disproportionally increased) might be a beneficial physiological effect. 
  A  cause  and  effect  relationship  has  been  established  between  the  consumption  of 
foods/beverages containing non-digestible carbohydrates instead of sugars and a reduction of 
post-prandial glycaemic responses as compared to sugar-containing foods/beverages. 
  The  following  wording  reflects  the  scientific  evidence:  “Consumption  of  foods/drinks 
containing non-digestible carbohydrates instead of sugars induces a lower blood glucose rise 
after meals compared to sugar-containing foods/drinks”. 
  In order to bear the claim, sugars should be replaced in foods or drinks by non-digestible 
carbohydrates so that foods or drinks contain reduced amounts of sugars as per Annex of 
Regulation (EC) No 1924/2006 and in accordance with the Guidance on the implementation 
of Regulation (EC) No 1924/2006 of the Standing Committee on the Food Chain and Animal 
Health for comparative nutrition claims made on foods
5. The target population is individuals 
who wish to reduce their post-prandial blood glucose responses. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on fructo-oligosaccharides (FOS) from inulin and reduction of post-prandial 
glycaemic responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006 (Claim serial No: 
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ABBREVIATIONS 
iAUC    incremental area under the curve 
DP    degree of polymerisation 
FOS    fructo-oligosaccharides 